Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The form of the drug, dose and strength prescribed is variable based on the practitioners preferred choice and the patients requirements
Microdosing semaglutide can, therefore, be cost-effective
Chang C
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
US$ 29.12
US$ 29.44
US$ 25.76
